Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

233
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
233
Positron Emission Tomography01:29

Positron Emission Tomography

5.4K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
5.4K
Brain Imaging01:14

Brain Imaging

308
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
308

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<sup>18</sup>F-fluorodeoxyglucose PET in Major Psychiatric Disorders.

PET clinics·2026
Same author

Multimodal neuroimaging of alcohol use: from acute neurochemical effects to chronic brain network reorganization and precision treatment targets.

Frontiers in neurology·2026
Same author

Amyloid burden, brain metabolism, and gray matter volume in SuperAgers.

Arquivos de neuro-psiquiatria·2026
Same author

Clinical Manifestations.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Quantifying metabolic decrement in brain FDG-PET of a complex frontotemporal dementia case.

Dementia & neuropsychologia·2025
Same author

Stable brain PET metabolic networks using a multiple sampling scheme.

Network neuroscience (Cambridge, Mass.)·2025
Same journal

Cost-effectiveness of imaging modalities in coronary heart disease: A comprehensive review.

Seminars in nuclear medicine·2026
Same journal

Letter from the Editors.

Seminars in nuclear medicine·2026
Same journal

Expanding Horizons: The Role of Kaleidoscope and Relevant Images in Seminars in Nuclear Medicine.

Seminars in nuclear medicine·2026
Same journal

The diagnostic performance and clinical value of [18F]FDG PET/CT in pleural mesothelioma - A systematic review and meta-analysis.

Seminars in nuclear medicine·2026
Same journal

Feasibility of treating neuroendocrine prostate cancer with anti-SSTR radioligands: A systematic review of imaging and treatment studies.

Seminars in nuclear medicine·2026
Same journal

<sup>18</sup>F-FDG -PET/CT in cardiac sarcoidosis: Diagnosis, therapy monitoring, and future directions.

Seminars in nuclear medicine·2026
See all related articles

Related Experiment Video

Updated: Sep 8, 2025

High-Resolution Cardiac Positron Emission Tomography/Computed Tomography for Small Animals
11:09

High-Resolution Cardiac Positron Emission Tomography/Computed Tomography for Small Animals

Published on: December 16, 2022

3.8K

PET Imaging in Psychiatric Disorders.

Rodolfo Ferrando1, Daniel Hernandes2, Bruno Galafassi Ghini3

  • 1Clinics Hospital, Universidad de la República (UDELAR), Montevideo, Uruguay; Uruguayan Centre for Molecular Imaging (CUDIM), Montevideo, Uruguay.

Seminars in Nuclear Medicine
|June 21, 2025
PubMed
Summary
This summary is machine-generated.

Positron emission tomography (PET) reveals brain metabolism and neurotransmitter changes in psychiatric disorders like schizophrenia and depression. This imaging technique aids in diagnosis, predicts treatment response, and advances personalized psychiatric care.

More Related Videos

Author Spotlight: Standardizing Mouse In Vivo PET Imaging with Body Conforming Molds and Automated Analysis
07:45

Author Spotlight: Standardizing Mouse In Vivo PET Imaging with Body Conforming Molds and Automated Analysis

Published on: October 25, 2024

485
Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
08:40

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

4.2K

Related Experiment Videos

Last Updated: Sep 8, 2025

High-Resolution Cardiac Positron Emission Tomography/Computed Tomography for Small Animals
11:09

High-Resolution Cardiac Positron Emission Tomography/Computed Tomography for Small Animals

Published on: December 16, 2022

3.8K
Author Spotlight: Standardizing Mouse In Vivo PET Imaging with Body Conforming Molds and Automated Analysis
07:45

Author Spotlight: Standardizing Mouse In Vivo PET Imaging with Body Conforming Molds and Automated Analysis

Published on: October 25, 2024

485
Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
08:40

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

4.2K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Medical Imaging

Background:

  • Positron emission tomography (PET) is crucial for investigating psychiatric disorders.
  • It allows in vivo assessment of brain metabolism, neurotransmitter dynamics, receptor binding, synaptic density, and neuroinflammation.

Purpose of the Study:

  • To review the utility of PET imaging in understanding the pathophysiology of major psychiatric conditions.
  • To explore its potential in clinical decision-making and personalized psychiatric care.

Main Methods:

  • Review of current evidence on PET imaging in schizophrenia, mood disorders, ASD, ADHD, and addiction.
  • Analysis of findings from 18F-FDG-PET, functional PET (fPET), and receptor-specific PET tracers.
  • Inclusion of studies on neuroinflammation and synaptic density using PET.

Main Results:

  • PET consistently shows prefrontal hypometabolism in schizophrenia and depression.
  • It reveals dopaminergic, serotonergic, and glutamatergic dysregulation in various psychiatric disorders.
  • PET identifies neuroinflammatory signatures and synaptic density reductions, aiding differential diagnosis and treatment response prediction.

Conclusions:

  • PET imaging is transformative for precision psychiatry, offering insights into pathophysiology and enabling personalized care.
  • Advancements in radiopharmaceuticals and AI will facilitate wider clinical integration.
  • Expanded research and clinical application of PET are advocated for improved psychiatric assessment and treatment planning.